CSI Market
Sign In | Register

X4 Pharmaceuticals Inc (XFOR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access XFOR Annual Balance Sheets →
The data below summarizes X4 Pharmaceuticals Inc's balance sheet position from Jun 30 2025 to Jun 30 2026, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent208.00
Marketable Securities, Total MA12.87
Cash & Short-term Investments220.00
Accounts receivable2.05
Inventories5.50
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.34
Total Current Assets218.86
Equipment/Property/Plant Net1.44
Goodwill net17.35
Intangible Assets13.10
Other Assets, Noncurrent2.31
Research And Development Incentive Receivable-
Total Assets253.06
Liabilities
Accounts Payable, Current AC3.93
Accrued Liabilities, Current AC14.13
Other Liabilities, Current1.31
Total Current Liabilities19.37
Long-term debt75.00
Total Long-term Debt75.00
Derivative Liability, Noncurrent DE0.67
Other liabilities, Noncurrent2.58
Operating Lease Liability Current0.73
Operating Lease Liability Noncurrent-
Total Liabilities97.61
Stockholders' Equity
Common Stock Value0.10
Additional Paid In Capital Common Stock786.43
Retained Earnings / Accumulated Deficit-630.95
Accumulated Other Comprehensive Income-0.12
Other Equity-0.12
Common Stockholder's Equity155.45
Total Stockholder's Equity155.45
Liabilities & Stockholder's Equity253.06
4 historic quarters locked

Sign in to unlock the full X4 Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About X4 Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001501697-26-000068

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.